Diabetes Care Submission Guide: Process, Timeline & Editor Tips

Diabetes Care focuses on five main article types, but Original Articles and Clinical Research dominate accepted submissions. These papers typically fall into clinical trials, large observational studies, or mechanistic research with direct therapeutic implications.

• Clinical Trials and Intervention Studies: Randomized controlled trials testing diabetes treatments, prevention strategies, or management approaches. The journal wants studies powered for clinical endpoints - HbA1c reduction, cardiovascular outcomes, quality of life measures. Pilot studies with 50 patients don't make the cut unless they're addressing completely novel interventions with exceptional preliminary data.

• Large Cohort and Epidemiological Studies: Population-based research examining diabetes incidence, complications, or treatment outcomes across diverse populations. Diabetes Care specifically values studies that address health disparities and include underrepresented populations. Studies focusing exclusively on white, affluent populations face higher rejection rates.

• Mechanistic Research with Clinical Translation: Laboratory studies are acceptable if they directly connect to diabetes pathophysiology and include human validation. But the clinical relevance must be obvious, not aspirational. Papers that end with "these findings suggest potential therapeutic targets" without human data get rejected. Papers that demonstrate mechanism in human tissue or patient-derived samples while connecting to clinical phenotypes get serious consideration.

• Technology and Device Studies: Continuous glucose monitors, insulin delivery systems, digital health interventions - but only with robust clinical outcome data. The journal won't publish technology papers that focus on device performance without demonstrating patient benefit.

• Health Services and Outcomes Research: Studies examining diabetes care delivery, cost-effectiveness, or health system interventions. These papers need to show actual improvements in patient outcomes or care processes, not just associations or theoretical models.

What doesn't fit: Basic biochemistry or animal studies without human translation. Genetic association studies without functional validation or clinical application. Single-center case series. Review articles (they're commissioned, not submitted). Papers that treat diabetes as a secondary endpoint rather than the primary clinical focus.

Your cover letter determines whether editors send your paper for peer review or reject it at the desk. Diabetes Care editors want to see immediate clinical relevance and patient impact, not academic positioning.

Start with a one-sentence summary of your main finding and its clinical significance. "We demonstrate that twice-daily insulin dosing reduces HbA1c by 0.7% compared to once-daily dosing in patients with poorly controlled type 2 diabetes, with implications for the 15 million Americans with HbA1c above 8%." Not "We investigated insulin dosing strategies in diabetes management."

• Clinical Significance Paragraph: Explain exactly how your findings change patient care. Use specific numbers and populations. "This 0.7% HbA1c reduction translates to a 15% reduction in cardiovascular events based on UKPDS risk models, particularly important for the 40% of US diabetes patients who don't achieve glycemic targets with current standard care." The editors want to see you've thought through real-world implementation.

• Study Design Justification: Address why your study design answers the clinical question better than existing literature. Don't just cite gaps in knowledge - explain why your approach fills them definitively. "Previous studies examined insulin timing in controlled clinical settings, but our 12-month community-based trial with 1,200 patients from federally qualified health centers demonstrates effectiveness in real-world diabetes care delivery."

• Population and Generalizability: Diabetes Care values diverse populations and generalizable findings. Highlight if your study includes underrepresented groups or addresses health disparities. "Our cohort was 45% Hispanic, 30% Black, and 60% had annual household incomes below $40,000, reflecting the populations most affected by diabetes complications."

Avoid generic statements about advancing diabetes care or contributing to the literature. The editors read hundreds of these phrases weekly. Instead, use our journal cover letter template to structure specific, compelling arguments about patient impact and clinical translation.

• Closing Requirements: State that all authors have approved the manuscript, confirm no duplicate publication, and disclose any potential conflicts of interest. Include your contact information and availability for the review process. Keep the total length under 400 words - editors don't read longer cover letters carefully.

Diabetes Care's editorial process runs longer than most medical journals, with median time to first decision around 100-130 days. But the timeline varies dramatically based on where your paper goes in the process.

• Desk Review Phase (5-14 days): The editorial office conducts initial screening for formatting, completeness, and basic scope alignment. About 15% of submissions get rejected here for technical issues or obvious scope mismatches. You'll receive an immediate decision if your paper doesn't meet basic requirements.

• Editorial Review Phase (14-45 days): Associate editors evaluate papers that pass desk review for scientific merit and clinical significance. Roughly 40% of submissions get rejected at this stage without peer review. Papers that advance to peer review typically represent the top tier of clinical relevance and scientific rigor.

• Peer Review Phase (60-90 days): Diabetes Care uses two to three expert reviewers, usually practicing endocrinologists or diabetes researchers. The journal prioritizes reviewers who understand clinical implementation challenges, not just scientific methodology. This phase accounts for most of the timeline variability.

• Editorial Decision and Author Response (30-60 days): Most papers receive "major revision" decisions requiring substantial changes and additional analyses. Authors typically get 60 days to respond to reviewer comments. Minor revisions are rare and usually signal likely acceptance.

• Holiday and Conference Delays: Expect 2-3 week delays during major diabetes conferences (ADA Scientific Sessions in June, EASD in September) and year-end holidays. Plan your submission timing accordingly if you're targeting specific publication dates.

The journal doesn't provide status updates during peer review, but you can check your submission status through the ScholarOne portal. Reviewers occasionally request additional time, extending the timeline by 2-4 weeks.

Rejection from Diabetes Care doesn't mean your research isn't publishable - it might just need a different journal audience. Strategic backup planning saves months of submission cycles.

• Diabetes (ADA's second journal): Published by the same organization but focuses more on mechanistic research and basic science applications. It is a stronger option for papers with clear diabetes relevance but less direct clinical application. Timeline is typically 60-90 days to decision.

• Diabetes Research and Clinical Practice: Clinical focus similar to Diabetes Care but more accepting of smaller studies and international populations. It is well-respected in the diabetes community. Particularly good for health services research and implementation studies that might be too specialized for Diabetes Care.

• Journal of Diabetes and its Complications: Specializes in diabetes complications research - nephropathy, retinopathy, cardiovascular disease, neuropathy. Excellent choice if your Diabetes Care rejection mentioned that complications research isn't their primary focus.

For mechanistic research that didn't meet Diabetes Care's clinical threshold, consider Diabetes, Obesity and Metabolism or Diabetes Research. Both journals accept high-quality basic science with diabetes relevance.

Use our journal selection guide to match your paper's scope and impact level with appropriate alternatives. Don't automatically submit to lower-tier journals after a single rejection - sometimes the paper-journal fit was simply wrong for Diabetes Care's specific clinical focus.

Consider timing factors too. Some alternative journals have faster review cycles that might better match conference presentation deadlines or grant reporting requirements.

1. Diabetes Care author guidelines and manuscript requirements, American Diabetes Association
2. Diabetes Care journal homepage and article type information, American Diabetes Association
3. ScholarOne Manuscripts author support documentation
4. Recent Diabetes Care original investigations and clinical studies for scope and framing comparison